Hypomagnesemia in peritoneal and hybrid dialysis: prevalence, predictors, and association with atrial fibrillation
Clinical and Experimental Nephrology · 2026
DOI: 10.1007/s10157-025-02810-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Nephrology, 2026. Verfasst von Kenji Nakata und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Toho University Ohashi Medical Center, Tokyo, Japan. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Magnesium, Atrial Fibrillation, Renal Dialysis. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Although hypomagnesemia is theoretically induced by the peritoneal dialysis (PD) environment, its real-world risk and clinical correlates remain unclear, and its association with atrial fibrillation (AF) has not been evaluated. METHODS: We conducted a cross-sectional study using nationwide data from the 2019 annual survey of the Japanese Society for Dialysis Therapy. Adults (≥ 20 years) undergoing hemodialysis (HD) or PD were included. Serum magnesium (sMg) was categorized into five groups (≤ 1.5, > 1.5- ≤ 2.0, > 2.0- ≤ 2.5, > 2.5- ≤ 3.0, and > 3.0 mg/dL). The prevalence of hypomagnesemia (≤ 1.5 mg/dL) was compared among PD-only, hybrid, and HD patients. Among PD-only and hybrid patients, the association between sMg and AF was examined using logistic regression. Factors associated with sMg levels were further analyzed using a general linear model. RESULTS: A total of 2,347 PD, 806 hybrid, and 177,779 HD patients were analyzed. The prevalence of hypomagnesemia was 6.2% in PD-only, 3.6% in hybrid, and 0.5% in HD patients. Hypomagnesemia was significantly associated with AF (adjusted OR 2.96, 95% CI 1.64-5.33). Lower sMg levels were associated with higher renal Kt/V, higher total daily dialysate volume, use of icodextrin, and higher peritoneal equilibration test dialysate-to-plasma ratio, whereas higher sMg levels were associated with greater ultrafiltration volume, use of automated PD, and hybrid dialysis. CONCLUSIONS: Hypomagnesemia is common in PD and is associated with an increased prevalence of AF. Further studies are warranted to identify the optimal sMg range for AF prevention and to develop PD prescription strategies for maintaining appropriate sMg levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Toho University Ohashi Medical Center, Tokyo, Japan.
- Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima, 960-1295, Japan.
- Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima, 960-1295, Japan. kuritanoriaki@gmail.com.
- Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukushima, Japan. kuritanoriaki@gmail.com.
- The Subcommittee of Statistical Analysis, The Committee of Renal Data Registry, The Japanese Society for Dialysis Therapy, Tokyo, Japan. kuritanoriaki@gmail.com.
- The Committee of Renal Data Registry, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
Zitieren
APA
Nakata, K., Toida, T., Kurita, N., Abe, M., Hanafusa, N., & Joki, N. (2026). Hypomagnesemia in peritoneal and hybrid dialysis: prevalence, predictors, and association with atrial fibrillation. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-025-02810-9
Vancouver
Nakata K, Toida T, Kurita N, Abe M, Hanafusa N, Joki N. Hypomagnesemia in peritoneal and hybrid dialysis: prevalence, predictors, and association with atrial fibrillation. Clinical and Experimental Nephrology. 2026. doi:10.1007/s10157-025-02810-9
BibTeX
@article{Nakata2026,
author = {Nakata, Kenji and Toida, Tatsunori and Kurita, Noriaki and Abe, Masanori and Hanafusa, Norio and Joki, Nobuhiko},
title = {Hypomagnesemia in peritoneal and hybrid dialysis: prevalence, predictors, and association with atrial fibrillation},
journal = {Clinical and Experimental Nephrology},
year = {2026},
doi = {10.1007/s10157-025-02810-9}
}
EUVIMED